1. WHO classification of tumors of the breast;Lakhani,2012
2. Page DL, Kidd TE, Dupont WD, Simpson JF, Rogers LW. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 1991;22(12):1232–1239http://www.ncbi.nlm.nih.gov/pubmed/1748429. Accessed September 18, 2017.
3. Degnim AC, Visscher DW, Berman HK, et al. Stratification of breast cancer risk in women with atypia: a Mayo Cohort Study. J Clin Oncol 2007;25(19):2671–2677http://www.ncbi.nlm.nih.gov/pubmed/17563394. Accessed September 18, 2017.
4. Chuba PJ, Hamre MR, Yap J, et al. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol 2005;23(24):5534–5541http://www.ncbi.nlm.nih.gov/pubmed/16110014. Accessed September 18, 2017.
5. Anderson SJ, Wapnir I, Dignam JJ, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five national surgical adjuvant breast and bowel project protocols of node-negative breast cancer. J Clin Oncol 2009;27(15):2466–2473http://www.ncbi.nlm.nih.gov/pubmed/19349544. Accessed September 20, 2017.